Fingerprint
Dive into the research topics where Piero Fossati is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
APOG: ACCESS POINT Oncology
Podar, K. (PI), Stoiber-Sakaguchi, D. (CoPI), Pecherstorfer, M. (CoPI), Georg, P. (CoPI), Kieseberg, P. (CoPI), Fossati, P. (CoPI), Lütgendorf-Caucig, C. (CoPI) & Slade, D. (CoPI)
01.01.2020 → 31.12.2026
Project: Funded Research
Research output
-
Clinical White Paper From the “Hadrontherapy for Life” Symposium–Clinical Expansion of Carbon Ion Facilities Worldwide
Thariat, J., Letellier, V., Ohno, T., Yamada, S., Fossati, P., Orlandi, E., Harrabi, S., Balosso, J., Gaubert, G., Haghdoost, S. & Habrand, J. L., Mar 2026, In: International Journal of Particle Therapy. 19, 101290.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Impact of dose and dose-averaged linear energy transfer on oro-pharyngeal-mucosal toxicity in patients with non-squamous head and neck cancers treated with carbon-ion radiotherapy
Nachankar, A., Gora, J., Schafasand, M., Fuß, M., Hug, E., Carlino, A., Lütgendorf-Caucig, C., Stock, M. & Fossati, P., Jan 2026, In: Radiotherapy and Oncology. 214, p. 111314 111314.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Carbon / Hadron therapy - A clinical focus
Fossati, P., Sept 2025.Research output: Contribution to conference › Invited talk/keynote at a conference
-
Carbon Ion Radiotherapy (CIRT) for Salivary Glands Tumors (SGT) with skull base infiltration: early results of a monocentric retrospective study
Di Christina, L., Hug, E. B., Nachankar, A., Romanello, D., Lütgendorf-Caucig, C., Tubin, S., Mozes, P., Góra, J., Carlino, A. & Fossati, P., Mar 2025.Research output: Contribution to conference › Poster at a conference
-
Carbon ion radiotherapy as a dose escalation tool in the treatment of primary high-risk prostate cancer
Moll, M., Fossati, P., Lütgendorf-Caucig, C. & Hug, E., 01 Sept 2025, In: Current Opinion in Urology. 35, 5, p. 568-573 6 p.Research output: Journal article (peer-reviewed) › Review article
1 Link opens in a new tab Citation (Scopus)